Biological effects and use of PrPSc- and PrP-specific antibodies generated by immunization with purified full-length native mouse prions

Benjamin Petsch, Andreas Müller-Schiffmann, Anna Lehle, Elizabeta Zirdum, Ingrid Prikulis, Franziska Kuhn, Alex J Raeber, James W Ironside, Carsten Korth, Lothar Stitz

Research output: Contribution to journalArticlepeer-review

Abstract

The prion agent is the infectious particle causing spongiform encephalopathies in animals and humans and is thought to consist of an altered conformation (PrP(Sc)) of the normal and ubiquitous prion protein PrP(C). The interaction of the prion agent with the immune system, particularly the humoral immune response, has remained unresolved. Here we investigated the immunogenicity of full-length native and infectious prions, as well as the specific biological effects of the resulting monoclonal antibodies (MAbs) on the binding and clearance of prions in cell culture and in in vivo therapy. Immunization of prion knockout (Prnp(0/0)) mice with phosphotungstic acid-purified mouse prions resulted in PrP-specific monoclonal antibodies with binding specificities selective for PrP(Sc) or for both PrP(C) and PrP(Sc). PrP(Sc)-specific MAb W261, of the IgG1 isotype, reacted with prions from mice, sheep with scrapie, deer with chronic wasting disease (CWD), and humans with sporadic and variant Creutzfeldt-Jakob disease (CJD) in assays including a capture enzyme-linked immunosorbent assay (ELISA) system. This PrP(Sc)-specific antibody was unable to clear prions from mouse neuroblastoma cells (ScN2a) permanently infected with scrapie, whereas the high-affinity MAb W226, recognizing both isoforms, PrP(Sc) and PrP(C), did clear prions from ScN2a cells, as determined by a bioassay. However, an attempt to treat intraperitoneally prion infected mice with full-length W226 or with a recombinant variable-chain fragment (scFv) from W226 could only slightly delay the incubation time. We conclude that (i) native, full-length PrP(Sc) elicits a prion-specific antibody response in PrP knockout mice, (ii) a PrP(Sc)-specific antibody had no prion-clearing effect, and (iii) even a high-affinity MAb that clears prions in vitro (W226) may not necessarily protect against prion infection, contrary to previous reports using different antibodies.
Original languageEnglish
Pages (from-to)4538-46
Number of pages9
JournalJournal of Virology
Volume85
Issue number9
DOIs
Publication statusPublished - 2011

Fingerprint Dive into the research topics of 'Biological effects and use of PrPSc- and PrP-specific antibodies generated by immunization with purified full-length native mouse prions'. Together they form a unique fingerprint.

Cite this